Global Biosimilar Market Ву Туре (Rituximab, Infliximab, Abciximab), Ву Аррlісаtіоn (Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency ), Ву Rеgіоn, By Key Players and Forecast to 2031


Report ID
31013
Published Date
15-Dec-2021
Delivery Format
PDF
No of Report Page
50
Editor's Rating
US $3999
US $5999
US $6999

The Report named “Global Biosimilar Market” serves crucial perceptions into global Biosimilar industry along with newfangled industry details, currently dominating players in Biosimilar, chapter wise analysis of each section and looming industry trends, which will guide the readers to target Biosimilar market product Specifications and clients driving the long-term market revenue and profitability.

The Scope of the Biosimilar Market Report:

This report mainly focuses on Biosimilar industry in the global market. This report primarily covers Biosimilar market in North America, Biosimilar market in Europe, Biosimilar market in Middle East and Africa, Biosimilar Market in Latin America and Asia Pacific. This report segregates the Biosimilar market based on Type, Competitive Players, Regions and Application.

Biosimilar Market: Key Players/Manufacturers Analysis

Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics SA

Biosimilar Market: Type Analysis

Rituximab
Infliximab
Abciximab
Trastuzumab
Adalimumab
Bevacizumab

Biosimilar Market: Applications Analysis

Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases

Biosimilar Market: Regional/Counties Analysis

The market is spread across the globe which not only includes Biosimilar market in Europe (Germany, France, Italy, Russia, and UK), Biosimilar market in North America (Canada, USA, and Mexico) but also Biosimilar market in Asia-Pacific(China, India, Korea and Japan). Now Biosimilar industry is also spread in the Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)and Rest of the World. Use of advanced technology is constraining the Biosimilar global market in North America. Europe will show a enormous elevation in the growth of global for Biosimilar industry due to increased use of Biosimilar in various fields. Asia Pacific countries such as China and India will show enormous growth in the Biosimilar global market due to rise in job opportunities.

Global Biosimilar market report also includes Biosimilar Market Business Overview. It also includes Biosimilar Market by Applications and Type, Biosimilar Revenue, Sales and Price and Biosimilar Business Share. This report of Biosimilar Market research also consists Global Biosimilar Market Competition, by Biosimilar market revenue of regions, sales and by Biosimilar industry competitive Players, (2015-2020).

Report on (2021 Biosimilar Market Report) mainly covers 15 Section and keenly display’s the global Biosimilar market:

Chapter 1 describes Biosimilar Introduction, product scope, Biosimilar market overview, market opportunities, market driving force, market risk;

Chapter 2 analyzes the top competitive players of global Biosimilar, with revenue, Biosimilar industry sales, and price of Biosimilar, in 2019 and 2020;

Chapter 3 displays the competitive situation of Biosimilar among the top competitive players, with sales, revenue and market share in Biosimilar Market in 2019 and 2020;

Chapter 4 shows the global Biosimilar market by regions, with market sales, revenue and share of Biosimilar, for each region, from 2016 to 2020;

Chapter 5, 6, 7, 8 and 9 analyzes the critical regions, with revenue, sales, and market share of Biosimilar market by key countries in these regions;

Chapter 10 and 11 shows the worldwide Biosimilar market by type and application, with sales channel, Biosimilar market share and growth rate by type, Biosimilar industry application, from 2016 to 2020;

Chapter 12 includes global Biosimilar market forecast, by regions, type and application, Biosimilar with sales and revenue, from 2021 to 2031;

Chapter 13, 14 and 15 describes Biosimilar distributors, dealers, Biosimilar traders, sales channel, research findings and conclusion, appendix and data source.

Do Inquiry Before Accessing Report Here https://market.us/report/biosimilar-market/#inquiry

Table of Contents

1 Market Overview

1.1 Biosimilar Introduction

1.2 Market Analysis by Type

1.2.1 Human Growth Hormones

1.2.2 Monoclonal Antibodies

1.2.3 Insulin

1.2.4 Peptides

1.2.5 Erythropoietin

1.2.6 Others

1.3 Market Analysis by Applications

1.3.1 Oncology

1.3.2 Chronic and Autoimmune Diseases

1.3.3 Growth Hormone Deficiency

1.3.4 Infectious Diseases

1.3.5 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2015-2031)

1.4.1.2 Canada Market States and Outlook (2015-2031)

1.4.1.3 Mexico Market States and Outlook (2015-2031)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2015-2031)

1.4.2.2 France Market States and Outlook (2015-2031)

1.4.2.3 UK Market States and Outlook (2015-2031)

1.4.2.4 Russia Market States and Outlook (2015-2031)

1.4.2.5 Italy Market States and Outlook (2015-2031)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2015-2031)

1.4.3.2 Japan Market States and Outlook (2015-2031)

1.4.3.3 Korea Market States and Outlook (2015-2031)

1.4.3.4 India Market States and Outlook (2015-2031)

1.4.3.5 Southeast Asia Market States and Outlook (2015-2031)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2015-2031)

1.4.4.2 Egypt Market States and Outlook (2015-2031)

1.4.4.3 Saudi Arabia Market States and Outlook (2015-2031)

1.4.4.4 South Africa Market States and Outlook (2015-2031)

1.4.4.5 Nigeria Market States and Outlook (2015-2031)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan plc

2.1.1 Business Overview

2.1.2 Biosimilar Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.2 BIOCAD

2.2.1 Business Overview

2.2.2 Biosimilar Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.3 Biocon

2.3.1 Business Overview

2.3.2 Biosimilar Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.4 BioXpress Therapeutics SA

2.4.1 Business Overview

2.4.2 Biosimilar Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BioXpress Therapeutics SA Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.5 Boehringer Ingelheim GmbH

2.5.1 Business Overview

2.5.2 Biosimilar Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Boehringer Ingelheim GmbH Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.6 Celltrion Inc.

2.6.1 Business Overview

2.6.2 Biosimilar Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Celltrion Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.7 Coherus BioSciences, Inc

2.7.1 Business Overview

2.7.2 Biosimilar Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Coherus BioSciences, Inc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.8 Dr. Reddy?s Laboratories Ltd.

2.8.1 Business Overview

2.8.2 Biosimilar Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dr. Reddy?s Laboratories Ltd. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.9 Genor BioPharma Co. Ltd

2.9.1 Business Overview

2.9.2 Biosimilar Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Genor BioPharma Co. Ltd Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.10 Intas Pharmaceuticals Limited

2.10.1 Business Overview

2.10.2 Biosimilar Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.11 Novartis AG

2.11.1 Business Overview

2.11.2 Biosimilar Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Novartis AG Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.12 Pfizer, Inc.

2.12.1 Business Overview

2.12.2 Biosimilar Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Pfizer, Inc. Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.13 Reliance Life Sciences

2.13.1 Business Overview

2.13.2 Biosimilar Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Reliance Life Sciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

3 Global Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer (2019-2020)

3.1 Global Biosimilar Sales and Market Share by Manufacturer (2019-2020)

3.2 Global Biosimilar Revenue and Market Share by Manufacturer (2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Biosimilar Manufacturer Market Share in 2021

3.3.2 Top 6 Biosimilar Manufacturer Market Share in 2021

3.4 Market Competition Trend

4 Global Biosimilar Market Analysis by Regions

4.1 Global Biosimilar Sales, Revenue and Market Share by Regions

4.1.1 Global Biosimilar Sales and Market Share by Regions (2015-2020)

4.1.2 Global Biosimilar Revenue and Market Share by Regions (2015-2020)

4.2 North America Biosimilar Sales and Growth Rate (2015-2020)

4.3 Europe Biosimilar Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Biosimilar Sales and Growth Rate (2015-2020)

4.5 South America Biosimilar Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Biosimilar Sales and Growth Rate (2015-2020)

5 North America Biosimilar by Countries

5.1 North America Biosimilar Sales, Revenue and Market Share by Countries

5.1.1 North America Biosimilar Sales and Market Share by Countries (2015-2020)

5.1.2 North America Biosimilar Revenue and Market Share by Countries (2015-2020)

5.2 United States Biosimilar Sales and Growth Rate (2015-2020)

5.3 Canada Biosimilar Sales and Growth Rate (2015-2020)

5.4 Mexico Biosimilar Sales and Growth Rate (2015-2020)

6 Europe Biosimilar by Countries

6.1 Europe Biosimilar Sales, Revenue and Market Share by Countries

6.1.1 Europe Biosimilar Sales and Market Share by Countries (2015-2020)

6.1.2 Europe Biosimilar Revenue and Market Share by Countries (2015-2020)

6.2 Germany Biosimilar Sales and Growth Rate (2015-2020)

6.3 UK Biosimilar Sales and Growth Rate (2015-2020)

6.4 France Biosimilar Sales and Growth Rate (2015-2020)

6.5 Russia Biosimilar Sales and Growth Rate (2015-2020)

6.6 Italy Biosimilar Sales and Growth Rate (2015-2020)

7 Asia-Pacific Biosimilar by Countries

7.1 Asia-Pacific Biosimilar Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Biosimilar Sales and Market Share by Countries (2015-2020)

7.1.2 Asia-Pacific Biosimilar Revenue and Market Share by Countries (2015-2020)

7.2 China Biosimilar Sales and Growth Rate (2015-2020)

7.3 Japan Biosimilar Sales and Growth Rate (2015-2020)

7.4 Korea Biosimilar Sales and Growth Rate (2015-2020)

7.5 India Biosimilar Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Biosimilar Sales and Growth Rate (2015-2020)

8 South America Biosimilar by Countries

8.1 South America Biosimilar Sales, Revenue and Market Share by Countries

8.1.1 South America Biosimilar Sales and Market Share by Countries (2015-2020)

8.1.2 South America Biosimilar Revenue and Market Share by Countries (2015-2020)

8.2 Brazil Biosimilar Sales and Growth Rate (2015-2020)

8.3 Argentina Biosimilar Sales and Growth Rate (2015-2020)

8.4 Colombia Biosimilar Sales and Growth Rate (2015-2020)

9 Middle East and Africa Biosimilar by Countries

9.1 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Biosimilar Sales and Market Share by Countries (2015-2020)

9.1.2 Middle East and Africa Biosimilar Revenue and Market Share by Countries (2015-2020)

9.2 Saudi Arabia Biosimilar Sales and Growth Rate (2015-2020)

9.3 UAE Biosimilar Sales and Growth Rate (2015-2020)

9.4 Egypt Biosimilar Sales and Growth Rate (2015-2020)

9.5 Nigeria Biosimilar Sales and Growth Rate (2015-2020)

9.6 South Africa Biosimilar Sales and Growth Rate (2015-2020)

10 Global Biosimilar Market Segment by Type

10.1 Global Biosimilar Sales, Revenue and Market Share by Type (2015-2020)

10.1.1 Global Biosimilar Sales and Market Share by Type (2015-2020)

10.1.2 Global Biosimilar Revenue and Market Share by Type (2015-2020)

10.2 Human Growth Hormones Sales Growth and Price

10.2.1 Global Human Growth Hormones Sales Growth (2015-2020)

10.2.2 Global Human Growth Hormones Price (2015-2020)

10.3 Monoclonal Antibodies Sales Growth and Price

10.3.1 Global Monoclonal Antibodies Sales Growth (2015-2020)

10.3.2 Global Monoclonal Antibodies Price (2015-2020)

10.4 Insulin Sales Growth and Price

10.4.1 Global Insulin Sales Growth (2015-2020)

10.4.2 Global Insulin Price (2015-2020)

10.5 Peptides Sales Growth and Price

10.5.1 Global Peptides Sales Growth (2015-2020)

10.5.2 Global Peptides Price (2015-2020)

10.6 Erythropoietin Sales Growth and Price

10.6.1 Global Erythropoietin Sales Growth (2015-2020)

10.6.2 Global Erythropoietin Price (2015-2020)

10.7 Others Sales Growth and Price

10.7.1 Global Others Sales Growth (2015-2020)

10.7.2 Global Others Price (2015-2020)

11 Global Biosimilar Market Segment by Application

11.1 Global Biosimilar Sales Market Share by Application (2015-2020)

11.2 Oncology Sales Growth (2015-2020)

11.3 Chronic and Autoimmune Diseases Sales Growth (2015-2020)

11.4 Growth Hormone Deficiency Sales Growth (2015-2020)

11.5 Infectious Diseases Sales Growth (2015-2020)

11.6 Others Sales Growth (2015-2020)

12 Biosimilar Market Forecast (2021-2031)

12.1 Global Biosimilar Sales, Revenue and Growth Rate (2021-2031)

12.2 Biosimilar Market Forecast by Regions (2021-2031)

12.2.1 North America Biosimilar Market Forecast (2021-2031)

12.2.2 Europe Biosimilar Market Forecast (2021-2031)

12.2.3 Asia-Pacific Biosimilar Market Forecast (2021-2031)

12.2.4 South America Biosimilar Market Forecast (2021-2031)

12.2.5 Middle East and Africa Biosimilar Market Forecast (2021-2031)

12.3 Biosimilar Market Forecast by Type (2021-2031)

12.3.1 Global Biosimilar Sales Forecast by Type (2021-2031)

12.3.2 Global Biosimilar Market Share Forecast by Type (2021-2031)

12.4 Biosimilar Market Forecast by Application (2021-2031)

12.4.1 Global Biosimilar Sales Forecast by Application (2021-2031)

12.4.2 Global Biosimilar Market Share Forecast by Application (2021-2031)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source